That bill, which became the Mental Health (Care and Treatment) (Scotland) Act 2003, received royal assent on 25 April 2003.In response to the petitioners' concerns about why the pharmaceutical company Lilly was allowed to sponsor a conference in September 2002, as part of the consultation process on the bill, the Executive states:"The conference … was organised by Holyrood Conferences and Events—not by the Scottish Executive".On being invited to clarify whether it is aware of any pharmaceutical company that indirectly promotes prescribed drugs for children by giving presentations to local authority education departments, the Executive has stated that it is"unaware of pharmaceutical companies giving presentations to such staff or to officials...